CAC
RBOT

Cowen and Company’s Vicarious Surgical RBOT Stock Holding History

Cowen and Company’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,333
Closed -$994K – 672
2021
Q1 		$994K Buy
+3,333
New +$1.02M 0.07% 138
2020
Q4 		– Sell
-4,569
Closed -$1.34M – 503
2020
Q3 		$1.34M Buy
+4,569
New +$1.34M 0.22% 73

Other funds holding RBOT

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
AC
Athanor Capital New York $24.6M AUM 2.49% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Capstone Investment Advisors
Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

Cowen and Company's RBOT Position: Q2 2021 in Review

Cowen and Company sold out of Vicarious Surgical (RBOT) in Q2 2021, closing a stake of 3,333 shares — an estimated $994K sold.

Cowen and Company first reported a position in RBOT in Q3 2020 and held it in 2 quarters. The position peaked at $1.34M in Q3 2020. 98 funds tracked by Wall St. Rank hold RBOT as of Q2 2021.

  • Cowen and Company reported no remaining Vicarious Surgical position as of Q2 2021 after selling out during the quarter.
  • Cowen and Company sold 3,333 Vicarious Surgical shares in Q2 2021, an estimated $994K.
  • Cowen and Company first reported a position in Vicarious Surgical in Q3 2020 and held it in 2 quarters.
  • Cowen and Company's Vicarious Surgical position peaked at $1.34M in Q3 2020.
  • 98 funds tracked by Wall St. Rank held Vicarious Surgical as of Q2 2021.

Based on Cowen and Company's 13F filing for Q2 2021, filed 13 Aug 2021.